6th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology
30 ESCO credits
12.04.2019 - 17.04.2019
Sibenik (Split area), Croatia
MASTERCLASS
Description
Chairs: A. Eniu, RO - C. Zielinski, AT
Host chair: E. Vrdoljak, HR
ESO Masterclass Coordinator: N. Pavlidis, GR
This residential programme has been designed for medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national board or ESMO exam. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. It is intended to cover all major topics of ESMO-ASCO curriculum on medical oncology. The programme focuses on cancer pathology and molecular biology, pharmacology of anti-cancer drugs and on frequent cancers such as breast, lung, gastro-intestinal, gynaecological and head and neck cancer. Spotlight sessions will provide inside on state of the art approaches in melanoma, sarcoma, thyroid cancer and on palliative care. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion. All participants will reside at the Masterclass venue and participation is mandatory throughout the course. At the end of each of the five days a learning self-assessment discussion with the chair of the course will be provided.
LEARNING OBJECTIVES
• To update the knowledge on basic science of clinical and medical oncology
• To enhance the competence and practical performance in systemic therapy of malignancies
• To enhance the competence and practical performance in multidisciplinary cancer care
• To update knowledge and get additional skills in supportive as well as palliative care
• To prepare for the board exam in clinical/medical oncology
MAIN TOPICS
• Cancer biology/pathology
• Cancer genetics
• Pharmacology of anti-cancer drugs
• Breast cancer
• Gastro-intestinal tumours
• Gynaecological tumours
• Head and neck cancers
• Lung cancer and mesothelioma
• Genito-urinary cancers
• Palliative and supportive care
• Haematological malignancies
The Eastern Europe |
![]() |
Faculty
FACULTY
J. Beyer, University Hospital Zürich, CH
S. Bosnjak, Institute of Oncology and Radiology of Serbia, Belgrade, RS
E. Brain, Marie Curie Institute, Paris, FR
M.J. Cardoso, Champalimaud Cancer Center, Lisbon, PT
P.G. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
S. Cascinu, Università di Modena e Reggio Emilia, Modena, IT
T. Cufer, University Clinic Golnik, Golnik, SI
A. Eniu, Cancer Institute « I. Chiricuta”, Cluj-Napoca, RO
F. B. Geara, American University of Beirut Medical Center, Beirut, LB
M. Halaska, Charles University and Faculty Hospital Kralovske Vinohrady, Prague, CZ
M.A. Hoda, Medical University Vienna, Vienna, AT
I. Kern, University Clinic Golnik, Golnik, SI
S. Martin Algarra, University Clinic of Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, ES
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, University Hospital of Ioannina, GR
R. Popescu, Hirslanden Klinik Aarau, CH
M. Porebiak, SWPS University of Social Sciences and Humanities, Warsaw, PL
C. Sessa, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
C. Sotiriou, Institut Jules Bordet, Brussels, BE
A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Tomic, Clinical Institute of Pathology KBC Split, Split, HR
J.B. Vermorken, Antwerp University Hospital, Edegem, BE
D. Vrbanec, University Hospital Zagreb, Zagreb, HR
E. Vrdoljak, Clinical Hospital Split, Medical School Split, Split, HR
C. Zielinski, Comprehensive Cancer Center Vienna, Vienna, AT
General information
ORGANISING SECRETARIAT
Dolores Knupfer and Laura Richetti
European School of Oncology (ESO)
Piazza Indipendenza 2
6500 Bellinzona
ph +41 91 820 09 52
e-mail: dknupfer@eso.net - lrichetti@eso.net
CME ACCREDITATION AND CERTIFICATE
The 6th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
The programme has been granted up to 26 European CME credits (ECMEC) . Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
The programme is furthermore accredited with 25 ESMO-MORA category 1 points.
Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.
INSURANCE
The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.
Application
IDEAL MASTERCLASS CANDIDATE
• Age between 30 and 40 years
• 2-3 years’ experience in oncology
• Involvement in scientific activities and clinical trials
• Fluency in English
PARTICIPATION
Admittance to the Masterclass is by competitive application. The successful applicants are granted free registration, full board, airport transfer to the course venue and accommodation in Split for the period 12-17 April 2019. Travel will be covered by the participants.
All participants will be expected to reside at the course venue and their full participation is compulsory throughout the course.
ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
THE APPLICATION DEADLINE HAS PASSED (18 DECEMBER 2018)
Programme
12 April
18:00 | Registration | |
18:30 | Welcome address and general introduction A. Eniu, RO - N. Pavlidis - GR, E. Vrdoljak, HR |
|
18:45 | Access to care: an old/new issue? Global and Eastern European issues A. Eniu, RO |
|
19:05 | Discussion | |
19:15 | Access to diagnoses and drugs in NSCLC in central and southeastern Europe T. Cufer, SI |
|
19:35 | Discussion |
|
20:00 | Dinner |
13 April
CLINICAL SESSION GENITO-URINARY TUMOURS Chairs: J. Beyer, CH - F.B. Geara, LB |
||
9:00 | Local therapy for prostate cancer (surgery and radiotherapy) F.B. Geara, LB |
|
9:20 | Discussion |
|
9:30 | Metastatic prostate cancer J. Beyer, CH |
|
9:50 | Discussion |
|
10:00 | Testicular cancer J. Beyer, CH |
|
10:20 | Discussion |
|
10:30 | Systemic treatment of advanced renal cancer M. Strijbos, BE |
|
11:50 | Discussion |
|
11:00 | Coffee break |
|
11:30 | Tumor board on genito-urinary tumours Faculty |
|
12:00 | Lunch |
|
SPOTLIGHT SESSION 1 Chair: N. Pavlidis, GR |
||
14:00 | Sarcomas P.G. Casali, IT |
|
14:20 | Discussion |
|
14:30 | GIST P.G. Casali, IT |
|
14:50 | Discussion |
|
15:00 | Coffee break | |
SPOTLIGHT SESSION 2 Chair: N. Pavlidis, GR |
||
15:30 | IPOS lecture: Communication skills as first level psycho-social care M. Porebiak, PL |
|
15:55 | Discussion | |
16:10 -17:40 |
PARTICIPANTS' CASE PRESENTATIONS (3 groups in parallel, 15 cases) A. Eniu, RO - R. Popescu, CH - N. Pavlidis, GR |
|
20:00 | Dinner |
14 April
CLINICAL SESSION BREAST CANCER Chairs: T. Cufer, SI - E. Vrdoljak, HR |
||
8:30 | Breast cancer pathology and molecular biology S. Tomic, HR |
|
8:50 | Discussion |
|
9:00 | Optimal surgical management of breast cancer M.J. Cardoso, PT |
|
9:20 | Discussion |
|
9:30 | The role of radiotherapy in early and advanced BC E. Vrdoljak, HR |
|
9:50 | Discussion |
|
10:00 | Coffee break |
|
10:30 | Optimal approach in locally advanced disease: ESO-ESMO ABC Guidelines D. Vrbanec, HR |
|
10:50 | Discussion |
|
11:00 | Systemic treatment of luminal early and advanced breast cancer A. Eniu, RO |
|
11:20 | Discussion |
|
11:30 | Systemic treatment of HER2-positive early and advanced BC T. Cufer, SI |
|
11:50 | |
Discussion |
12:00 |
Systemic treatment of TN early and advanced BC C. Sotiriou, BE |
|
12:20 | Discussion |
|
13:00 | Lunch |
|
SPOTLIGHT SESSION 3 Chairs: E. Brain, FR - A. Stathis, CH |
||
14:30 | Advances in the management of non-Hodgkin's lymphoma A. Stathis, CH |
|
14:50 | Discussion |
|
15:00 | Management of cancer in the elderly E. Brain, FR |
|
15:20 | Discussion |
|
15:30 | Coffee break |
|
16:00 | Tumor board on breast cancer | |
19:00 | Dinner |
15 April
CLINICAL SESSION LUNG CANCER AND MESOTHELIOMA Chairs: T. Cufer, SI - M.A. Hoda, AT |
||
9:00 |
Lung cancer pathology and molecular biology I. Kern, SI |
|
9:20 | Discussion |
|
9:30 | Surgery for lung cancer and malignant pleural mesothelioma M.A. Hoda, AT |
|
10:00 | Discussion |
|
10:10 | Optimal management of N2 disease M.A. Hoda, AT |
|
10:30 | Discussion |
|
10:40 | Coffee break |
|
11:00 | Chemotherapy and targeted agents in lung cancer (NSCLC and SCLC) T. Cufer, SI |
|
11:45 | Discussion |
|
11:55 | Systemic managemant of mesothelioma M.A. Hoda, AT |
|
12:15 |
Discussion |
|
12:25 | Immune check point inhibitors: Immunologic background, indications and innovations C. Zielinski, AT |
|
12:50 | Discussion |
|
13:00 | Lunch |
|
14:00 | Tumor board on lung cancer Faculty |
|
SPOTLIGHT SESSION 4 Chair: R. Popescu, CH |
||
15:15 | Systemic management of pancreatic cancer R. Popescu, CH |
|
15:35 |
Discussion |
|
15:45 | Palliative care S. Bosnjak, RS |
|
16:05 | Discussion |
|
16:15 | Supportive care S.Bosnjak, RS |
|
16:35 | Discussion | |
16:45 | Coffee break |
|
17:15 - 18:30 |
PARTICIPANTS' CASE PRESENTATIONS (3 groups in parallel, 15 cases) N. Pavlidis, GR - R. Popescu, CH - C. Zielinski, AT |
|
20:00 | Dinner |
16 April
CLINICAL SESSION GASTROINTESTINAL TUMOURS Chairs: S. Cascinu, IT - D. Papamichael, CY |
||
8:30 | Adjuvant/neoadjuvant systemic treatment of colorectal cancer S. Cascinu, IT |
|
8:50 | Discussion | |
9:00 | Systemic treatment of advanced colorectal cancer S. Cascinu, IT |
|
9:20 | Discussion | |
9:30 | Coffee break | |
10:00 | Management of rectal cancer D. Papamichael, CY |
|
10:20 | Discussion | |
10:30 | Systemic treatment of advanced gastric cancer D. Papamichael, CY |
|
10:50 | Discussion | |
11:00 | Tumour board on gastro-intestinal tumours S. Cascinu, IT - D. Papamichael, CY |
|
12:00 | Lunch | |
CLINICAL SESSION GYNAECOLOGICAL TUMOURS Chair: C. Sessa, CH |
||
13:00 | Screening of cervical cancer C. Sessa, CH |
|
13:30 | Discussion | |
13:40 | Role of surgery in gynaecological cancer M. Halaska, CZ |
|
14:10 | Discussion | |
14:20 | Systemic management of ovarian cancer J.B. Vermorken, BE |
|
14:50 | Discussion | |
15:00 | Systemic management of cervical and endometrial C. Sessa, CH |
|
15:40 | Discussion | |
15:50 | Coffee break | |
16:15 | Tumor board on gynaecological tumours Faculty |
|
CLINICAL SESSION HEAD AND NECK CANCERS Chair: N. Pavlidis, GR |
||
17:00 | Therapeutic management of head and neck cancers J.B. Vermorken, BE |
|
17:30 | Discussion |
|
17:40 | Tumour board on head and neck cancers J.B. Vermorken, BE |
|
19:00 |
Departure from hotel |
|
19:30 | Off-site dinner |
17 April
SPOTLIGHT SESSION 5 Chair: S. Martin-Algarra, ES |
||
9:00 | Management of melanoma with immunotherapy and targeted treatment S. Martin-Algarra, ES |
|
9:20 | Discussion | |
9:30 | The diagnostic and therapeutic management of Cancer of Unknown Primary N. Pavlidis, GR |
|
10:00 | Discussion | |
10:10 | Learning self-assessment test Chairs |
|
11:00 | Close Chairs |
|
11:30 | Standing lunch and departures |